Dutch enforcer probes drugmakers over excessive pricing and tying
The Dutch competition authority has launched a preliminary investigation to determine if three pharmaceutical companies are tying their services and charging excessive prices to both healthcare and insurance providers.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.